RARE logo

Ultragenyx Pharmaceutical Inc. (RARE) Short term debt

Annual short term debt:

$60.14M+$18.31M(+43.76%)
December 31, 2024

Summary

  • As of today (September 16, 2025), RARE annual short term debt is $60.14 million, with the most recent change of +$18.31 million (+43.76%) on December 31, 2024.
  • During the last 3 years, RARE annual short term debt has risen by +$49.08 million (+443.50%).
  • RARE annual short term debt is now at all-time high.

Performance

RARE Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRAREbalance sheet metrics

quarterly short term debt:

$75.63M+$7.77M(+11.44%)
June 30, 2025

Summary

  • As of today (September 16, 2025), RARE quarterly short term debt is $75.63 million, with the most recent change of +$7.77 million (+11.44%) on June 30, 2025.
  • Over the past year, RARE quarterly short term debt has increased by +$16.99 million (+28.98%).
  • RARE quarterly short term debt is now at all-time high.

Performance

RARE quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRAREbalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

RARE Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+43.8%+29.0%
3 y3 years+443.5%+550.2%
5 y5 years+731.3%+942.0%

RARE Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+443.5%at high+550.2%
5 y5-yearat high+731.3%at high+942.0%
alltimeall timeat high>+9999.0%at high>+9999.0%

RARE Short term debt History

DateAnnualQuarterly
Jun 2025
-
$75.63M(+11.4%)
Mar 2025
-
$67.86M(+12.8%)
Dec 2024
$60.14M(+43.8%)
$60.14M(+1.7%)
Sep 2024
-
$59.16M(+0.9%)
Jun 2024
-
$58.64M(+5.7%)
Mar 2024
-
$55.47M(+32.6%)
Dec 2023
$41.84M(+255.2%)
$41.84M(-0.4%)
Sep 2023
-
$42.00M(+21.4%)
Jun 2023
-
$34.61M(+133.9%)
Mar 2023
-
$14.79M(+25.6%)
Dec 2022
$11.78M(+6.4%)
$11.78M(-0.3%)
Sep 2022
-
$11.82M(+1.6%)
Jun 2022
-
$11.63M(+2.7%)
Mar 2022
-
$11.32M(+2.3%)
Dec 2021
$11.07M(+23.3%)
$11.07M(+3.4%)
Sep 2021
-
$10.70M(+3.8%)
Jun 2021
-
$10.30M(+9.9%)
Mar 2021
-
$9.38M(+4.5%)
Dec 2020
$8.98M(+24.1%)
$8.98M(+15.3%)
Sep 2020
-
$7.79M(+7.3%)
Jun 2020
-
$7.26M(-3.1%)
Mar 2020
-
$7.49M(+3.5%)
Dec 2019
$7.24M
$7.24M(-0.8%)
Sep 2019
-
$7.29M(+4.2%)
Jun 2019
-
$7.00M(+33.1%)
DateAnnualQuarterly
Mar 2019
-
$5.26M(>+9900.0%)
Dec 2018
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
Mar 2018
-
$0.00(0.0%)
Dec 2017
$0.00(0.0%)
$0.00(0.0%)
Sep 2017
-
$0.00(0.0%)
Jun 2017
-
$0.00(0.0%)
Mar 2017
-
$0.00(0.0%)
Dec 2016
$0.00(0.0%)
$0.00(0.0%)
Sep 2016
-
$0.00(0.0%)
Jun 2016
-
$0.00(0.0%)
Mar 2016
-
$0.00(0.0%)
Dec 2015
$0.00(0.0%)
$0.00(0.0%)
Sep 2015
-
$0.00(0.0%)
Jun 2015
-
$0.00(0.0%)
Mar 2015
-
$0.00(0.0%)
Dec 2014
$0.00(0.0%)
$0.00(0.0%)
Sep 2014
-
$0.00(0.0%)
Jun 2014
-
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
Dec 2013
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
Dec 2012
-
$0.00
Dec 2011
$0.00
-

FAQ

  • What is Ultragenyx Pharmaceutical Inc. annual short term debt?
  • What is the all time high annual short term debt for Ultragenyx Pharmaceutical Inc.?
  • What is Ultragenyx Pharmaceutical Inc. annual short term debt year-on-year change?
  • What is Ultragenyx Pharmaceutical Inc. quarterly short term debt?
  • What is the all time high quarterly short term debt for Ultragenyx Pharmaceutical Inc.?
  • What is Ultragenyx Pharmaceutical Inc. quarterly short term debt year-on-year change?

What is Ultragenyx Pharmaceutical Inc. annual short term debt?

The current annual short term debt of RARE is $60.14M

What is the all time high annual short term debt for Ultragenyx Pharmaceutical Inc.?

Ultragenyx Pharmaceutical Inc. all-time high annual short term debt is $60.14M

What is Ultragenyx Pharmaceutical Inc. annual short term debt year-on-year change?

Over the past year, RARE annual short term debt has changed by +$18.31M (+43.76%)

What is Ultragenyx Pharmaceutical Inc. quarterly short term debt?

The current quarterly short term debt of RARE is $75.63M

What is the all time high quarterly short term debt for Ultragenyx Pharmaceutical Inc.?

Ultragenyx Pharmaceutical Inc. all-time high quarterly short term debt is $75.63M

What is Ultragenyx Pharmaceutical Inc. quarterly short term debt year-on-year change?

Over the past year, RARE quarterly short term debt has changed by +$16.99M (+28.98%)
On this page